Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,941Revenue $M22.0Net Margin (%)-449.8Altman Z-Score44.6
Enterprise Value $M3,561EPS $-1.0Operating Margin %-476.5Piotroski F-Score5
P/E(ttm)--Beneish M-Score20.3Pre-tax Margin (%)-449.8Higher ROA y-yY
Price/Book9.310-y EBITDA Growth Rate %--Quick Ratio14.9Cash flow > EarningsY
Price/Sales1855-y EBITDA Growth Rate %--Current Ratio14.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-19.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-21.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.5ROIC % (ttm)-144.0Gross Margin Increase y-yN

Gurus Latest Trades with NBIX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NBIXGeorge Soros 2013-09-30 Sold Out -0.03%$10.6 - $16.7
($13.79)
$ 45.58231%Sold Out0
NBIXGeorge Soros 2013-06-30 Buy 0.03%$10.9 - $13.57
($12.28)
$ 45.58271%New holding200,000
NBIXJoel Greenblatt 2012-12-31 Sold Out -0.13%$6.88 - $8.66
($7.6)
$ 45.58500%Sold Out0
NBIXJoel Greenblatt 2012-06-30 Add0.03%$6.31 - $8.06
($7.18)
$ 45.58535%Add 23.80%259,903
NBIXGeorge Soros 2012-06-30 Sold Out -0.02%$6.31 - $8.06
($7.18)
$ 45.58535%Sold Out0
NBIXJoel Greenblatt 2012-03-31 Buy 0.15%$7.33 - $9.79
($7.95)
$ 45.58473%New holding209,930
NBIXGeorge Soros 2012-03-31 Buy 0.02%$7.33 - $9.79
($7.95)
$ 45.58473%New holding150,000
NBIXGeorge Soros 2011-12-31 Sold Out -0.0018%$5.5 - $8.58
($6.76)
$ 45.58574%Sold Out0
NBIXGeorge Soros 2011-09-30 Reduce$5.59 - $8.44
($6.71)
$ 45.58579%Reduce -23.93%17,800
NBIXGeorge Soros 2011-06-30 Add$6.82 - $8.3
($7.54)
$ 45.58505%Add 90.24%23,400
NBIXGeorge Soros 2011-03-31 Add$6.47 - $7.84
($7.2)
$ 45.58533%Add 23.00%12,300
NBIXGeorge Soros 2010-12-31 Buy $5.99 - $8.53
($7.63)
$ 45.58497%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NBIX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NBIX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Gano KyleChief Business Development Off 2016-04-11Sell41,770$44.023.54view
OBrien Christopher FlintChief Medical Officer 2016-04-06Sell25,000$451.29view
OBrien Christopher FlintChief Medical Officer 2016-02-03Sell1,500$38.0119.92view
Grigoriadis Dimitri E.Chief Research Officer 2016-02-03Sell1,375$37.9820.01view
GORMAN KEVIN CHARLESPresident and CEO 2016-02-03Sell3,125$38.0419.82view
Gano KyleChief Business Development Off 2016-02-03Sell1,375$37.9820.01view
Coughlin Timothy PCFO 2016-02-03Sell1,500$38.0619.76view
Bozigian Haig P.Chief Development Officer 2016-02-03Sell1,375$38.1319.54view
OBrien Christopher FlintChief Medical Officer 2016-01-19Sell1,750$46.77-2.54view
Grigoriadis Dimitri E.Chief Research Officer 2016-01-19Sell1,625$46.76-2.52view

Quarterly/Annual Reports about NBIX:

News about NBIX:

Articles On GuruFocus.com
Meridian Funds Comments on Neurocrine Biosciences Aug 31 2015 
Meridian Contrarian Fund Annual Report 2015 Aug 31 2015 
Weekly Insider Sells Highlight: ORCL, TWC, FB, NBIX Jan 13 2014 
5 Strong Healthcare Stocks For 2012 Mar 24 2012 
Consider These 5 Healthcare Stocks Now Mar 21 2012 
Neurocrine Biosciences Inc. (NBIX) VP and CFO Timothy P Coughlin sells 12,320 Shares Mar 02 2011 
Neurocrine Biosciences Inc. (NBIX) President and CEO Kevin Charles Gorman sells 15,400 Shares Mar 02 2011 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Oct 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Jul 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Apr 29 2010 

More From Other Websites
Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2016 Results Apr 29 2016
Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2016 Results Apr 29 2016
Neurocrine Biosciences to Present at the Deutsche Bank 41st Annual Health Care Conference Apr 27 2016
Neurocrine Biosciences to Present at the Deutsche Bank 41st Annual Health Care Conference Apr 27 2016
Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys Apr 18 2016
Is there any Upside in Neurocine Biosciences, Inc? (NBIX) Apr 11 2016
Neurocrine Biosciences (NBIX) Stock Gets 'Outperform' Rating at BMO Capital Apr 07 2016
Neurocrine Biosciences’ Valbenazine Launch: What You Need to Know Apr 06 2016
3 Hot Biotechs Highlight Jefferies Growth Stocks to Buy This Week Apr 05 2016
Neurocrine Biosciences, Inc. – Value Analysis (NASDAQ:NBIX) : April 4, 2016 Apr 04 2016
Will Elagolix Make Neurocrine Biosciences a Key Women’s Health Name? Apr 01 2016
Neurocrine Biosciences, Inc. breached its 50 day moving average in a Bullish Manner : NBIX-US :... Apr 01 2016
ETF’s with exposure to Neurocrine Biosciences, Inc. : March 31, 2016 Mar 31 2016
How Does Neurocrine Biosciences’ Valuation Compare to Peers? Mar 31 2016
Neurocrine Biosciences, Inc. :NBIX-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 30 2016
Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference Mar 09 2016
Neurocrine Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference Mar 02 2016
Neurocrine Biosciences Announces the Acceptance of Three Scientific Abstracts for Valbenazine... Mar 02 2016
Top Biotech Picks of Best-Performing Hedge Fund of 2015 Feb 27 2016
NBIX: Valbenazine NDA to be Filed in 2016… Feb 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)